Cryomass Technologies

Cryomass Technologies EBIT Margin

The EBIT Margin (Operating Margin) of Cryomass Technologies (CRYM) as of Nov 19, 2026 is -43,824.19 %. In the previous year, EBIT Margin (Operating Margin) was -836.24 % — a change of 5,140.62% (lower).

EBIT Margin

-43,824.19 %

YoY

5,140.62%

Last updated:

EBIT Margin (Operating Margin) of Cryomass Technologies is 2023 -43,824.19 % . EBIT Margin (Operating Margin) of Cryomass Technologies was 2022 -836.24 % . It decreases by 5,140.62% lower compared to the previous year.

Cryomass Technologies's operating (EBIT) margin stands at -43,824.2%, down from -5.6% several years earlier.

The Cryomass Technologies EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2010
-0.01 USD
Jan 1, 2011
-0.05 USD
Jan 1, 2012
-0.06 USD
Jan 1, 2013
-0.07 USD
Jan 1, 2019
-86.83 USD
Jan 1, 2020
-836.24 USD
Jan 1, 2023
-43,824.19 USD
The Cryomass Technologies EBIT Margin history
YEAREBIT MarginYoY
-43,824.19 %+5,140.62%
-836.24 %+863.12%
-86.83 %+127,245.17%
-0.07 %+21.36%
-0.06 %+8.99%
-0.05 %+420.62%
-0.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryomass Technologies Stock analysis

What does Cryomass Technologies do? CryoMass Technologies, Inc. operates medical marijuana dispensaries and related businesses, leveraging patented technology that utilizes liquid nitrogen to separate, collect, and protect high-value compounds from harvested plants. The firm owns a Trichome Separation unit, known as the CryoMass patented liquid nitrogen system, which is optimized for capturing fully intact cannabis and hemp trichomes along with terpenes. This system stabilizes and collects trichomes at harvest, preventing wasteful loss and functioning effectively within minutes after plants are cut or on fresh frozen and dried plant parts including trim. The company generates revenue by selling its proprietary Trichome Separation system to entities involved in the cultivation and processing of cannabis and hemp. By offering a solution that efficiently captures valuable compounds from various plant states, CryoMass Technologies targets customers seeking to maximize yield and quality in the medical marijuana sector. The business model relies on the unique capabilities of its liquid nitrogen technology to provide a superior alternative to traditional extraction methods, appealing to dispensaries and related businesses looking to enhance their operational efficiency and product integrity. Cryomass Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryomass Technologies stock

EBIT Margin (Operating Margin) of Cryomass Technologies is -43,824.19 % in 2023.

EBIT Margin (Operating Margin) of Cryomass Technologies changed from -836.24 % to -43,824.19 %, representing a 5,140.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Cryomass Technologies since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Cryomass Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cryomass Technologies

All Key Metrics — Cryomass Technologies